MCVRX | VMVAX | MCVRX / VMVAX | |
Total Expense Ratio | 1.24 | 0.07 | 1,771% |
Annual Report Gross Expense Ratio | 1.25 | 0.07 | 1,786% |
Fund Existence | 22 years | 14 years | - |
Gain YTD | -7.344 | -4.477 | 164% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 3000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.9B | 29.9B | 53% |
Annual Yield % from dividends | 0.65 | 2.33 | 28% |
Returns for 1 year | -8.17 | 2.95 | -277% |
Returns for 3 years | -0.46 | 7.81 | -6% |
Returns for 5 years | 60.11 | 77.68 | 77% |
Returns for 10 years | 44.32 | 70.27 | 63% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SATO | 15.60 | 0.51 | +3.39% |
Invesco Alerian Galaxy Crypto Eco ETF | |||
IHE | 66.74 | 0.65 | +0.98% |
iShares US Pharmaceuticals ETF | |||
EHI | 6.39 | 0.05 | +0.79% |
Western Asset Global High Income Fund | |||
XT | 57.65 | 0.42 | +0.73% |
iShares Exponential Technologies ETF | |||
ECNS | 27.16 | -0.35 | -1.27% |
iShares MSCI China Small-Cap ETF |